postinfectious syndrome U09.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Patients with COVID-19 infection confirmed by PCR test or official antigen test infection or medically confirmed COVID-19 infection based on doctor's letters/documentation treating physicians, whereby the COVID infection occurred at least 4 weeks ago ? or patients with post-infectious syndrome after other medically documented infection (e.g. EBV, influenza, CMV) ? Symptoms cannot be explained by alternative diagnoses and are related to the infection ? Age at least 18 years ? Capable of giving consent ? Sufficient mobility so that an outpatient clinic can be visited ? Sufficient knowledge of German The study team decides on the final inclusion or exclusion.
Exclusion criteria
Exclusion criteria: ? Alcohol or drug addiction ? Patients who are hospitalised by court order ? Any indications of acute suicidal behaviour ? Pregnancy (anamnestic) ? Lack of hearing and vision that cannot be compensated for with aids. The decision is made by the study team.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| overall: An improved understanding of Long-COVID symptoms in their development over time, overlaps and possible correlations at neurological, psychiatric and geriatric level after continuous recording and monitoring over a period of 3 months. more precisely: 1. Evaluation of the predictability of pre-clinically measured data from the MAPS & orthostatic heart frequency variations during the ANS standing examination with regard to the clinical examination for PoTS. 2. Documentation of cognitive function impairments & psychological symptoms over time and their correlation with orthostasis parameters 3.Validation of the added value of pre-clinical psychological symptom registration via digital tool. 4. Evaluation of the added value of continuous psychological symptom monitoring for long Covid via digital tool. 5. Examining the usefulness of registering mobility and risk of falling in geriatric patients via digitally assisted TUG, as well as registration of daily fluid intake. 6.Examining the effect of daily drink- and medication reminders via digital tool on regular therapy compliance. | — |
Secondary
| Measure | Time frame |
|---|---|
| The usefulness and acceptance of the ADELE digital health assistance system by patients in everyday life and the associated potential increase in patient autonomy. | — |
Countries
Germany
Contacts
Universitätsklinikum Aachen